Residual immune dysregulation syndrome in treated HIV infection. - Wikidata - thesis-toulmin - TriplyDB

Residual immune dysregulation syndrome in treated HIV infection.

Residual immune dysregulation syndrome in treated HIV infection.

http://www.wikidata.org/entity/Q34020121

about

Animal Models for HIV Cure Research HIV and aging: emerging research issues Understanding frailty, aging, and inflammation in HIV infection IL-21 and probiotic therapy improve Th17 frequencies, microbial translocation, and microbiome in ARV-treated, SIV-infected macaques.A Review of Management of Inflammation in the HIV Population Immune Activation Influences SAMHD1 Expression and Vpx-mediated SAMHD1 Degradation during Chronic HIV-1 Infection Ageing and inflammation in patients with HIV infection.A pilot study of brisk walking in sedentary combination antiretroviral treatement (cART)- treated patients: benefit on soluble and cell inflammatory markers.Coagulation and morbidity in treated HIV infection.Setting Performance Standards for a Cost-Effective Human Immunodeficiency Virus Cure Strategy in South Africa.Promotion of a subdominant CD8 T cell response during murine gammaherpesvirus 68 infection in the absence of CD4 T cell help Inflammation, Immune Activation, and Antiretroviral Therapy in HIV Treatment of HIV infection with a raltegravir-based regimen increases LDL levels, but improves HDL cholesterol efflux capacity.Dysregulation of multiple inflammatory molecules in lymph node and ileum of macaques during RT-SHIV infection with or without antiretroviral therapy Sevelamer does not decrease lipopolysaccharide or soluble CD14 levels but decreases soluble tissue factor, low-density lipoprotein (LDL) cholesterol, and oxidized LDL cholesterol levels in individuals with untreated HIV infection HIV cure strategies: how good must they be to improve on current antiretroviral therapy?Chronic Inflammation: Accelerator of Biological Aging.The effect of HAART-induced HIV suppression on circulating markers of inflammation and immune activation.The CD14 C-260T single nucleotide polymorphism (SNP) modulates monocyte/macrophage activation in treated HIV-infected individuals.Prospective immune dynamics during the first 24 weeks of efavirenz based-antiretroviral therapy in HIV-1-infected subjects, according to CD4+ T-cell counts at presentation: the IMMUNEF clinical trial Intestinal microbiota, microbial translocation, and systemic inflammation in chronic HIV infection Using the pathogenic and nonpathogenic nonhuman primate model for studying non-AIDS comorbidities.Oxidized LDL Levels Are Increased in HIV Infection and May Drive Monocyte Activation.Immune aging, dysmetabolism, and inflammation in neurological diseases.Survival and HLA-B*57 in HIV/HCV Co-Infected Patients on Highly Active Antiretroviral Therapy (HAART).Reduction of soluble CD163, substance P, programmed death 1 and inflammatory markers: phase 1B trial of aprepitant in HIV-1-infected adults.Bone health in HIV-infected children, adolescents and young adults: a systematic review.Prolonged Antiretroviral Therapy Preserves HIV-1-Specific CD8 T Cells with Stem Cell-Like Properties Comparison of the Immunogenicity of Various Booster Doses of Inactivated Polio Vaccine Delivered Intradermally Versus Intramuscularly to HIV-Infected Adults.Plasma CXCL10, sCD163 and sCD14 Levels Have Distinct Associations with Antiretroviral Treatment and Cardiovascular Disease Risk Factors.Gut Mucosal Barrier Dysfunction, Microbial Dysbiosis, and Their Role in HIV-1 Disease Progression.Vitamin D and Calcium Attenuate Bone Loss With Antiretroviral Therapy Initiation: A Randomized Trial.CD4/CD8 Ratio and KT Ratio Predict Yellow Fever Vaccine Immunogenicity in HIV-Infected Patients Obesity Is Not Associated with Impaired Immune Response to Influenza Vaccination in HIV-Infected Persons HIV-1 gp120 envelope glycoprotein determinants for cytokine burst in human monocytes.CD8 T-Cell Expansion and Inflammation Linked to CMV Coinfection in ART-treated HIV Infection.Elevated Levels of Microbial Translocation Markers and CCL2 Among Older HIV-1-Infected Men Regulatory T Cells, Frailty, and Immune Activation in Men Who Have Sex With Men in the Multicenter AIDS Cohort Study The Association of Human Cytomegalovirus with Biomarkers of Inflammation and Immune Activation in HIV-1-Infected Women.Inflammation Perturbs the IL-7 Axis, Promoting Senescence and Exhaustion that Broadly Characterize Immune Failure in Treated HIV Infection.

P2860

Q26767476-35A33A82-46F6-4B9E-9617-579410431DEE Q27016011-E58AEDA0-D22D-439F-9A12-653C7AC53471 Q27021143-F6D888B4-EBF3-4ADD-A248-BA6D09169C55 Q27320132-2F8CC604-7559-4A1B-9A39-50C437D82B0B Q28078962-EA747468-CF58-4A65-AA69-CF789A2635FE Q28589591-3312FBCC-DFCE-4491-88B3-70DF8735C32E Q30244296-A59A3A42-CB21-43E6-B5B4-3AFAAF7F4601 Q30365593-ABBFC018-0B7B-4386-A7EF-F626254AE6AF Q33614424-AB9912A4-FBB4-4B63-8EBB-07D97275517D Q33851741-EBE9FC0E-9DC6-4A37-A1A3-83C8CC61CA8F Q33900288-FF68508E-4794-4BF1-BF02-AB5740E99CC4 Q33912595-BFC491FF-CBD8-44B6-AA3C-B94A2F9977C9 Q33917580-47CA6B2D-92C4-4C49-AD60-6B1B640F04C1 Q34250336-2536FD33-8BFD-4FC8-AC26-BA00C5DACDD4 Q34430215-2C75DD81-922A-433D-AE59-662B545C14A4 Q34514601-00E5A173-1EA7-452A-B199-EB3E01B3295E Q34680346-8BE12F04-13CC-4CED-ACAE-5CCECF017968 Q35030011-1923DC90-13B3-4FB7-BC26-9AD1BCCFEF46 Q35030351-A615DE65-0684-4F7E-AED4-B8D3DB0C1905 Q35074381-2675E144-5A8B-4E1B-90E1-95E2F1FC32F0 Q35078598-9493C03B-B030-4BD9-8A1D-86428A43E428 Q35204909-5CC48CD3-FE95-4EFA-976E-83A073A5F93B Q35655728-CA0DE77C-214B-41B4-B9E5-89D64DB549A5 Q35677347-1D1A2F2F-6CE5-4088-8FFE-44B16617E6E8 Q35737580-A5520AC9-1EF7-4152-9708-756235CE4BE2 Q35755634-F27EA4E2-6FC9-4999-9ABB-4A5C86F7BC96 Q35822412-6C816320-D632-4A2A-81B9-3BBDBF9E4765 Q35861157-2154FB93-1B12-46A1-84E8-36DCB45AA911 Q35965234-DD2C129B-E56E-4BE9-85E0-D721297B285B Q36063953-A0C5A697-5622-4DE4-B11F-802021B9CBF5 Q36132003-0F210C69-F0C4-426A-9EE6-6D5EA9095107 Q36170370-79722123-396A-4CE1-B33D-B426C48D9628 Q36219873-9BD33C4F-3BE1-4B33-BF0D-98A59725A31A Q36241275-33355CA1-D82B-4CC9-9653-50863B4969EC Q36323975-678996C5-D445-416F-B6AA-9126577F139D Q36446109-6B01A5AA-25D7-4E95-8932-67B645C38210 Q36562863-EFDA5B25-6EA0-44BB-B904-DF10B4BFB65C Q36573561-E6B44913-0B33-4850-A688-E439A899C77C Q36601953-FFDE1B61-37EE-4A22-A92D-5F15BE1C887E Q36678143-589E827D-B49D-4C2D-94AE-EF433C6B4229

P2860

Residual immune dysregulation syndrome in treated HIV infection.

http://www.wikidata.org/entity/Q34020121

description

2013 nî lūn-bûn

@nan

2013 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Residual immune dysregulation syndrome in treated HIV infection.

@ast

Residual immune dysregulation syndrome in treated HIV infection.

@en

Residual immune dysregulation syndrome in treated HIV infection.

@nl

type

label

Residual immune dysregulation syndrome in treated HIV infection.

@ast

Residual immune dysregulation syndrome in treated HIV infection.

@en

Residual immune dysregulation syndrome in treated HIV infection.

@nl

prefLabel

Residual immune dysregulation syndrome in treated HIV infection.

@ast

Residual immune dysregulation syndrome in treated HIV infection.

@en

Residual immune dysregulation syndrome in treated HIV infection.

@nl

P1433

Q34020121-C232EA73-75FD-4C88-95F3-E7FB64FB4E36

P1476

Q34020121-ACA3E673-BF40-415F-9498-315947826B19

P2093

Q34020121-361DC819-F6BC-4331-80FF-3B04E649A571

Q34020121-78031956-C716-4258-B92F-7687DF9B98D9

Q34020121-AF737B46-2901-4099-B92E-E2FACC2FACE9

Q34020121-DFD4F654-196F-4D38-9915-059D3CCF40DF

P2860

Q34020121-002F9EA2-921A-499A-A67A-A1A0031600F9

Q34020121-00F8E2E0-4CA1-4DB4-B00F-B104B44AB196

Q34020121-01B9FB9C-70DD-4419-A23B-F0C722370464

Q34020121-0810AD0C-225D-4BAC-BCA2-C1C6689C2EFF

Q34020121-085F3E5D-CB95-44BE-8DC8-0978E76F41FE

Q34020121-0885965D-567C-4646-8C28-1DFEDD3CBC2F

Q34020121-0A022DBF-B939-4DA7-912F-A9DB6F156F65

Q34020121-0A88E8E6-734A-4F40-A03E-F1FE52425D3A

Q34020121-0C474E75-8136-4CA4-8F41-6495FF42996F

Q34020121-0ED34539-8383-4A43-ABEE-D545497A1500

P304

Q34020121-1B713D14-071C-4EE7-B2CE-A5ECE57E691B

P31

Q34020121-0AFFB642-E921-4F65-A269-F7CC3FCCEF27

P356

Q34020121-C7F6EE12-B3C9-4EC8-9C2C-645A2C7DDE4A

P478

Q34020121-168B7EFD-EC4C-48F3-90A4-4A3211C7FDD0

P50

Q34020121-4078CD2C-AD64-43F2-861F-134BE17B9E35

P577

Q34020121-1E6F27CA-6E73-46F2-9741-437D3C634818

P698

Q34020121-E14DFA98-8FAC-47EC-A6ED-B8427839B904

P932

Q34020121-C4D16683-9CBC-4DF3-9163-0BEA55B1BDD8

P356

B978-0-12-407707-2.00002-3

P1433

Advances in Immunology

P1476

Residual immune dysregulation syndrome in treated HIV infection.

@en

P2093

Michael M Lederman

http://www.w3.org/2001/XMLSchema#string

Nicholas T Funderburg

http://www.w3.org/2001/XMLSchema#string

Nichole R Klatt

http://www.w3.org/2001/XMLSchema#string

Peter W Hunt

http://www.w3.org/2001/XMLSchema#string

P2860

Antiretroviral therapy and the prevalence of osteopenia and osteoporosis: a meta-analytic review

Life expectancy of recently diagnosed asymptomatic HIV-infected patients approaches that of uninfected individuals

CD4+ T cell depletion during all stages of HIV disease occurs predominantly in the gastrointestinal tract

Microbial translocation is a cause of systemic immune activation in chronic HIV infection

HIV-1 envelope protein binds to and signals through integrin α4β7, the gut mucosal homing receptor for peripheral T cells

Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8

Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studies

CD36 ligands promote sterile inflammation through assembly of a Toll-like receptor 4 and 6 heterodimer

Idiopathic CD4+ lymphocytopenia: natural history and prognostic factors

The rising challenge of non-AIDS-defining cancers in HIV-infected patients

P304

51-83

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/B978-0-12-407707-2.00002-3

http://www.w3.org/2001/XMLSchema#string

P478

119

http://www.w3.org/2001/XMLSchema#string

P50

Rafick-Pierre Sekaly

P577

2013-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23886064

http://www.w3.org/2001/XMLSchema#string

P932

4126613

http://www.w3.org/2001/XMLSchema#string